Karoline Meagher
Associate Director, Precision Medicine Regeneron
Seminars
Thursday 10th December 2026
Harnessing siRNA Technologies to Achieve Precise Complement Modulation Across an Increased Range of Indications
11:30 am
- Exploring the advantages of siRNA-based approaches for reducing complement protein production and enabling durable pathway inhibition
- Assessing target selection, dosing strategies and safety considerations to optimize efficacy across complement-mediated diseases
- Demonstrating how next-generation RNA technologies are expanding treatment options and addressing unmet patient needs
